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A B S T R A C T
Axonal and neuronal degeneration are important features of multiple sclerosis (MS) and other neurologic disorders
that affect the anterior visual pathway. Optical coherence tomography (OCT) is a non-invasive technique that allows im-
aging of the retinal layers. Our aim was to examine retinal nerve fiber layer (RNFL) thickness and macular volume
(MV), measred by OCT, in patients with history of optic neuritis (ON). Patients with chronic ON had significantly de-
creased mean RNFL thickness and total MV when compared to acute ON eyes, controls and unaffected fellow eyes. There
was also statistically significant difference between two chronic groups, with lower values in group with history of acute
ON. OCT provides us unique insight in structural changes in the anterior visual pathway, therefore it may complement
our existing diagnostic tests and, as a potential outcome measure, help develop more effective therapeutic strategies for
ON and MS patients.
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Introduction
Optic neuritis (ON), one of the most common and
characteristic manifestations during the course of the
multiple sclerosis (MS), results from the development of
an inflammatory demyelinating lesion in the optic ner-
ve1–4. Consequently, optic nerve and retinal nerve fibre
layer (RNFL) manifest axonal and neuronal degenera-
tion1,5.
The development of axonal loss and secondary retinal
ganglion cell (neuronal) loss in the macula can be quanti-
fied with optical coherence tomography (OCT), by imag-
ing and measuring the RNFL thickness and MV1,6–8.
OCT is a simple, noninvasive, highly sensitive, pre-
cise, quantitative and reproducible technique that pro-
vides us in vivo high-resolution reconstruction and objec-
tive measurements of the thickness of the peripapillary
mean RNFL (mRNFL), foveal, and macular thickness,
macular volumes and segmentation of retinal layers2,5,8–11.
Validation of OCT as an imaging biomarker in MS is im-
portant, because several aspects of the information it
generates are unique. Imaging RNFL with ocular imag-
ing techniques allows direct measurement of the most
proximal region of the anterior visual pathway and this
unique central nervous system (CNS) structure, because
it is composed of unmyelinated axons of retinal ganglion
cells, all the way to lamina cribrosa2,8,9,12.
RNFL thinning, which represents axonal damage, in
the eye of a patient with ON or MS, may function as a
biomarker of global disease severity13,14. Therefore, RNFL
is an ideal model for investigating the effects of standard
and novel therapies on processes of axonal and neuronal
degeneration, neuroprotection and, potentially, even ne-
urorepair. Therefore, OCT can be an useful outcome
measure in clinical trials investigating these thera-
pies2,5,8,9,15.
Based on OCT studies, it is confirmed that RNFL
thickness and MV is significantly reduced in patients
with a history of optic neuritis. Several studies showed
that even eyes without acute demyelinating optic neuri-
tis among MS patients or unilateral ON patients have de-
creased RNFL thickness over time, compared with the
eyes of control subjects5,7–9,16–18.
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OCT and its measurements of retinal layers thinning
following ON or MS relapse could be considered as a po-
tential outcome measure in MS clinical trials, but there
is not enough dana on the reproducibility of this tech-
nique in MS centers8. Therefore, the objective of this
study was to determine the current capabilities of OCT
to detect changes in RNFL and MV integrity following
ON, by measuring mRNFL and total MV.
Materials and Methods
We performed retrospective study of 33 patients (66
eyes), administered in our Clinic from July 2010 to the
end of 2011, with the history of acute or chronic ON in at
least one eye. Patients with some other acompanying oc-
ular pathologies were excluded.
Patients' eyes were divided in several groups: 20 eyes
with acute ON, 19 unaffected fellow eyes (non-ON eyes),
eyes with chronic ON with (13 eyes) or withouth previ-
ous history of acute attack (14 eyes) and finally, 23
healthy control eyes.
SD-OCT (Spectral domain OCT, Copernicus HR (Op-
topol Technology S.A.)) measurement of mean peripa-
pillary RNFL thickness as well as total macular volume
in 6 mm diameter were performed.
The main outcome measures included comparing dif-
ferences in RNFL thickness and MV between groups, us-
ing Student’s t-test.
Mean time from acute ON attack was 4.3 years.
RNFL thinning with age had been estimated at 0.3
mm/year or a decrease of approximately 0.27%/year6. This
emphasized the need for age-matched healthy controls. We
consider our patients speciment correspondent, because
mean patients age was 37.7 years and controls 36 years.
Results
Eyes with acute ON had elevated mRNFL (124 mm)
values by 12.9% compared to control eyes (108 mm), al-
though statistical significance was not achieved. Total
MV did not show such increase of values (Table 1).
Both the mRNFL and total MV in the eyes not previ-
ously affected by ON (non-ON eyes), were not signifi-
cantly decreased, when compared to healthy control eyes.
Eyes of the patients with chronic ON and a history of
acute ON had significantly decreased mean RNFL thick-
ness (80.3 mm) compared to controls (108 mm) (p< 0.0001)
and to non-ON eyes (112 mm) (p<.0001). Also, the pa-
tients with chronic ON and a history of acute ON demon-
strated significantly decreased total MV (6.42 mm3) com-
pared to the control group (7.24 mm3) (p<0.0001) and
group with non-ON eyes (7.19 mm3) (p<0.0001, Table 1,
Figures 1 and 2).
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TABLE 1
RNFL AND MV COMPARISON AMONG GROUPS
Groups mRNFL (mm)
p value compared




Acute ON eyes 124 <0.23 6,76 <0.18
Chronic with history of acute ON 80.3 <0.0001 6.42 <0.0001
Chronic without history of acute ON 94.3 <0.0005 6,89 <0.036
Non-ON eyes 112 <0.39 7.19 <0.73
Control eyes 108 7.24
Fig. 1. Comparison of mRNFL in chronic ON eyes with
history of acute ON (A) and control eyes (B), p<0.0001.
Fig. 2. Comparison of MV in chronic ON eyes with history
of acute ON (A) and control eyes (B), p<0.0001.
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When comparing mRNFL of eyes with chronic ON,
but without history of acute ON (93.8 mm), we noticed
statistically significant difference to controls (108 mm)
(p<0.0005) and non-ON eyes (112 mm) (p<0.0018). Total
MV in the same group (6.89 mm3) also showed statisti-
cally significant difference when compared to control
eyes (7.24 mm3) (p<0.036) and non-ON eyes (7.19 mm3)
(p<0.043, Table 1).
A statisticaly significant difference in mRNFL (p<
0.03) and MV (p<0.028) was also found between eyes
with chronic ON and history of acute attack when com-
pared to eyes with chronic ON withouth previous history
of acute attack (Figures 3 and 4).
The mean RNFL thickness in chronic ON eyes with
history of acute ON (80.3 mm) (p<0.022), was reduced by
35.2% compared to eyes with acute ON (124 mm). The to-
tal MV in eyes with chronic ON and history of acute at-
tack (6.42 mm3) was decreased by 9.4% when compared
to eyes with acute ON (7.09 mm3).
There were no statistically significant results when
comparing mRNFL and MV in acute ON with control
and non-ON eyes.
Discussion and Conclusion
Whereas the reductions in RNFL thickness implicate
the loss of ganglion cell axons, macular changes indi-
rectly implicate loss of the ganglion cell neurons them-
selves1,5–8,12.
There is a quantifiable, highly significant loss of
mRNFL axons and total MV in patients eyes after acute
optic neuritis (ON). Reduced macular volumes accom-
panyed peripapillary RNFL thinning. This study con-
firmed an average 25.6% reduction in mRNFL thickness
in the chronicaly affected eyes of patients with previous
optic neuritis compared with the healthy control eyes (p
<0.0001), and an average 28.3% reduction when the af-
fected and unaffected eyes were compared (p<0.0001).
Thinning of the RNFL after optic neuritis has been con-
firmed in all subsequent studies6,7,19,20.
Total MV values decrease by approximately 11.3% in
the affected eyes compared to control eyes (p<0.001) and
by 10.7% when compared to non-ON eyes (p<0.001).
These findings are important because the inner retinal
complex (ganglion cell layer, inner plexiform and nuclear
layers) comprises 34% of the total average macular thick-
ness14. Thus, MV can indirectly give us informaton about
neuronal cell loss. Tracking macular volumes in ON pa-
tients may help determine the temporal relation between
primary neuronal cell death and axonal loss after a CNS
inflammatory event9. These observations are analogous
to studies of gray matter in MS14.
The mean RNFL of eyes with chronic ON, but without
history of acute ON was reduced by 15.1% when compared
to control eyes and by 19.4% when compared to non-ON
eyes. In the same group, total MV was 4.8% lower than in
control eyes, and 4.17% lower than in non-ON eyes.
The mean RNFL thickness was reduced in both chro-
nic ON groups (80.3/93.8 mm) relative to controls (108
mm) (p<0.0001 and p<0.001), with lower values noted in
the ON eyes with history of acute ON. Similarly, MV de-
creased in both chronic groups (6.42/6.89 mm3) relative
to controls (7.24 mm3) (p < 0.0001 /p< 0.001), with more
severe reduction in a group with history of ON.
Peripapillary RNFL thinning and MV loss are less
strongly linked in eyes with chronic ON without history
of acute ON, than in eyes of patients with a history of
ON.
Eyes of patients with acute ON had mRNFL 124 mm,
higher than control eyes (mRNFL 108 mm. Although the
difference was not statistically significant, we can see
that there is increase in mRFNL due to the disc edema.
This could also explain the more pronounced difference
in mRNFL reduction comparing the chronic ON with
acute ON group (35.2%) than with control group (25.6%).
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Fig. 3. Comparison of mRNFL in chronic ON eyes with
history of acute ON (A) and chronic ON eyes without
history of acute attack (B), p<0.03.
Fig. 4. Comparison of MV in chronic ON eyes with history
of acute ON (A) and chronic ON eyes without history of
acute attack (B), p<0.028.
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It is important to be aware of such effects, because poten-
tial swelling during the acute stages of ON may confound
baseline measurements10. Total MV, which indirectly re-
presents ganglion cell layer, did not demonstrate swelling
in acute phase, when compared with controles and con-
tralateral unaffected eyes, whereas mild peripapillary
retinal nerve fibre layer oedema was observed in affected
eyes. Total MV was lower in participants with acute ON
than in controls, although statistical significance was not
achieved. Total MV in chronic ON and history of acute
attack showed significant reduction compared to acute
ON eyes (9.4%), which is similar to comparison with con-
trol eyes (reduction of 11.3%), due to the absence of MV
values increase in acute phase.
In unaffected fellow eyes, both the mean RNFL thick-
ness and MV were not reduced when compared with con-
trol values, which is not in concordance with other stu-
dies12,14,17.
The most reproducible RNFL measurement in our
study was mean RNFL, showing the greatest dfferences,
which correlates with previously published results6,7,19,20.
In our study, mean time from acute ON in chronic ON
group was 4.3 years. As was noted in previous studies,
RNFL thinning is usually evident within 3 months of an
acute ON event and achieves stabilization in an overall
12 months period. This period is a potential therapeutic
»window« and it is important for the design of future trials
employing OCT as an outcome measure in ON patients9,12,21.
Our speciment, with mean time over 14 months in chro-
nic phase, is representative for clinical trials design.
In conclusion, this study has demonstrated structur-
ally relevant changes indicative of axonal loss and retinal
neuronal cell loss in the RNFL and macula, respectively,
after optic neuritis, measured by OCT.
There is increasing evidence suggesting a role of OCT
in the evaluation of ON and MS patients. It is an estab-
lished technique used to measure RNFL thickness and
macular volume (MV), a measurement that may provide
information relating to visual pathway axonal loss and
neuronal cell thinning following ON10,14.
Results from our study demonstrate retinal neuronal
layer thinning following acute optic neuritis, corroborat-
ing the hypothesis that axonal injury may cause neuro-
nal pathology in ON or MS. The data from this study
may be used to provide reference values for the develop-
ment of clinical trial protocols.
Our results support validity of RNFL thickness as a
structural marker for axonal degeneration and support
other recent findings about the use of OCT, quantitative
and noninvasive imaging technique, and its retinal layer
segmentation as an outcome measure in clinical trials
that examine neuroprotective and other disease-modify-
ing experimental therapies7,8,10,20,22.
Limitations
We performed retrograde study, in which we only had
one OCT scan, however, results from other studies on the
same subject indicate that a single scan can provide reli-
able results8.
The major limitation of our study was the small sam-
ple size studied. When a patient population size is lim-
ited, interpretation of results might not be as objective,
even in the context of an elegantly designed study9.
Therefore, further controlled, prospective clinical trials
involving a larger numbers of patients will be needed to
firmly establish the role of OCT in ON and MS and how
this technology can be optimally implemented in devel-
oping new therapeutic strategies in ON patients.
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VA@NOST OPTI^KE KOHERENTNE TOMOGRAFIJE (OCT) KOD OPTI^KOG NEURITISA (ON)
S A @ E T A K
Degeneracija aksona i neurona je va`na u patogenezi multiple skleroze (MS) i kod drugih neurolo{kih bolesti koje
zahva}aju prednji dio vidnog puta. Opti~ka koherentna tomografija (OCT) je neinvazivna tehnika koja omogu}ava sni-
manje sloja retinalnih `iv~anih vlakana (RNFL). Cilj na{eg ispitivanja bio je ispitati debljinu RNFL i volumen makule
(VM) kod pacijenata s opti~kim neuritisom (ON), mjerene OCT-om. Kada smo ih usporedili s o~ima s akutnim ON, sa
nezahva}enim drugim okom i kontrolnom skupinom, o~i pacijenata s kroni~nim ON su imale zna~ajno sni`ene srednje
vrijednosti debljine RNFL-a (mRNFL) i ukupnog VM. Tako|er smo dobili statisti~ki zna~ajnu razliku izme|u dvije
kroni~ne grupe, s ni`im vrijednostima u grupi s prethodnim akutnim ON. OCT omogu}uje jedinstven uvid u struktural-
ne promjene prednjeg dijala vidnog puta, te mo`e dopuniti uobi~ajeni spektar pretraga i pomo}i u razvijanju efikasnijih
strategija lije~enja pacijenata s ON i MS.
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